Pain Management

Naloxone education often requires difficult but necessary conversations with patients.

Patients with diabetes and depression may have a lower risk of mortality and diabetes complications when taking antidepressants regularly, according to a new study.

Drug overdose deaths, including opioid-related deaths, have increased rapidly in the United States in recent years, according to preliminary data from the CDC.

When counseling a patient with constipation, it is important to review the patient’s medication list to determine the potential cause.

Become an expert in naloxone to help educate patients.

Individuals with opioid misuse disorders may be experiencing decreased access to naloxone during the COVID-19 pandemic.

A study presented at the American Academy of Neurology’s 73rd Annual Meeting aimed to identify predictors of acute treatment optimization in individuals with migraine

A session held at the HOPA Annual Meeting 2021 discussed best practices for optimizing opioid treatment in patients with cancer pain.

A 25-year study examines triptan use as an acute treatment strategy for migraines in a Danish population.

Pharmacists can counsel on prescription and OTC options, as well as nonpharmacologic measures.

Keynote speaker Dan Schneider, from the Netflix documentary “The Pharmacist,” discusses his story and mission to end the opioid epidemic.

Americans in underserved communities face barriers to opioid use disorder treatment.

In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.

The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.

Patients reported more frequent and severe migraines, along with overuse of analgesics.

Tanvee Thakur, PhD, BPharm, recently completed a project focused on enhancing transparent opioid education.

Elizabeth Dragatsi, RPh, BCPS, worked on 2 projects integrating community pharmacists into contingency management and opioid education.

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

The Drug Topics® team rounded up some of our top-read articles from the last year.

You’ll be hard pressed to find a pharmacist as excited about change as Ashli Yoder, PharmD, the clinical services lead for Norland Avenue Pharmacy in Chambersburg, Pennsylvania.

Acetaminophen injection, 1000 mg/100 mL, is an FDA-approved generic to Ofirmev.

US prescription opioid use dropped 60% from its peak volume in 2011, according to a new report from the IQVIA Institute for Human Data Science.

Counsel patients on best practices for disposal of unused or expired pain medications.

The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.

A study presented during PAINWeek 2020 Live Virtual Conference highlights the role of e-consultations in reducing opioid use.

Add value by optimizing medications, decreasing pill burden.

Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.

A virtual session held during the NCPA 2020 Annual Convention discussed best practices for handling opioid prescriptions.

The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.

Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.